Latest linezolid Stories
PITTSBURGH, July 3 /PRNewswire-FirstCall/ -- Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Linezolid Tablets, 600 mg.
Basilea Pharmaceuticals has obtained regulatory approval from Health Canada for its anti-MRSA drug, ceftobiprole.
Targanta Therapeutics Corporation (Nasdaq: TARG) today announced that the European Medicines Agency (EMEA) has accepted for review its Marketing Authorization Application (MAA) for oritavancin, Targanta's novel semi-synthetic lipoglycopeptide antibiotic candidate with potent bactericidal (killing) activity against a broad spectrum of gram-positive bacteria.
NEW YORK, June 19 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc.
WASHINGTON (Reuters) - U.S. regulators warned Pfizer Inc. about "misleading promotion" of its antibiotic drug Zyvox in a professional journal, according to a letter released on Tuesday.
Jaydin was a 7-month-old female who was transferred to our facility from an outside hospital by ambulance after her father brought her into the emergency department (ED) for fever of 105, irritability, and epistaxis.
Enterococcus is a Gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals. It is a main constituent of some probiotic food supplements. E. faecalis can cause life-threatening infections in humans, especially in the nosocomial environment, where the naturally high levels of antibiotic resistance found in E. faecalis contribute to its pathogenicity. It is frequently found in root canal-treated teeth in prevalence values ranging from 30% to 90% of...
Enterococcus faecalis "“ formerly classified as part of the Group D Streptococcus system "“ is a Gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals. It is one of the main constituents of some probiotic food supplements. E. faecalis can cause life-threatening infections in humans. It is frequently found in root canal-treated teeth in prevalence values ranging from 30% to 90% of the cases. It is a non-motile, facultatively anaerobic...